Brief: Cannara Biotech Secures Conditional Approval To List On The TSX Exchange
11/03/2021 14:23
March 11 (Reuters) - Cannara Biotech Inc LOVE.CD :
* CANNARA BIOTECH SECURES CONDITIONAL APPROVAL TO LIST ON
THE TSX
EXCHANGE
Source text for Eikon: ID:nCNWDXwXxa
Further company coverage: LOVE.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04